Impact of the 2009 (7th Edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Chu, Vicki H ^a   Tetzlaff, Michael T ^b   Torres Cabala, Carlos A ^b   Prieto, Victor G ^b   Bassett, Roland ^b   Gershenwald, Jeffrey E ^b   McLemore, Michael S ^b   Ivan, Doina ^b   Wang, Wei Lien ^b   Ross, Merrick I ^b   Curry, Jonathan L ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLASSIFICATION; HUMAN; MALE; MELANOMA; MIDDLE AGED; MITOSIS; PATHOLOGY; PROGNOSIS; SKIN TUMOR;

ADULT; AGED; HUMANS; MALE; MELANOMA; MIDDLE AGED; MITOSIS; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS;

EID: 84893722114     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/898719     Document Type: Article

References (52)

1. Rigel D. S., Epidemiology of melanoma. Seminars in Cutaneous Medicine and Surgery 2010 29 4 204 209 2-s2.0-79251509240 10.1016/j.sder.2010.10.005
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., Cancer statistics, 2009. CA: Cancer Journal for Clinicians 2009 59 4 225 249 2-s2.0-67650874081 10.3322/caac.20006
3. Frangos J. E., Duncan L. M., Piris A., Nazarian R. M., Mihm M. C. Jr., Hoang M. P., Gleason B., Flotte T. J., Byers H. R., Barnhill R. L., Kimball A. B., Increased diagnosis of thin superficial spreading melanomas: a 20-year study. Journal of the American Academy of Dermatology 2012 67 3 387 394 2-s2.0-82755176655 10.1016/j.jaad.2011.10.026
4. Jemal A., Saraiya M., Patel P., Cherala S. S., Barnholtz-Sloan J., Kim J., Wiggins C. L., Wingo P. A., Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. Journal of the American Academy of Dermatology 2011 65 5, supplement 1 S17.e1 S17.e11 2-s2.0-80054826924 10.1016/j.jaad.2011.04.032
5. Breslow A., Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Annals of Surgery 1970 172 5 902 908 2-s2.0-0014884119
6. Balch C. M., Buzaid A. C., Soong S. J., Atkins M. B., Cascinelli N., Coit D. G., Fleming I. D., Gershenwald J. E., Houghton A. J., Kirkwood J. M., McMasters K. M., Mihm M. F., Morton D. L., Reintgen D. S., Ross M. I., Sober A., Thompson J. A., Thompson J. F., Final version of the American joint committee on (Pubitemid 32786276)
7. Balch C. M., Gershenwald J. E., Soong S., Thompson J. F., Atkins M. B., Byrd D. R., Buzaid A. C., Cochran A. J., Coit D. G., Ding S., Eggermont A. M., Flaherty K. T., Gimotty P. A., Kirkwood J. M., McMasters K. M., Mihm M. C. Jr., Morton D. L., Ross M. I., Sober A. J., Sondak V. K., Final version of 2009 AJCC melanoma staging and classification. Journal of Clinical Oncology 2009 27 36 6199 6206 2-s2.0-74949143594 10.1200/JCO.2009.23.4799
8. Clark W. H. Jr., Elder D. E., Guerry D. T., Braitman L. E., Trock B. J., Schultz D., Synnestvedt M., Halpern A. C., Model predicting survival in stage I melanoma based on tumor progression. Journal of the National Cancer Institute 1989 81 24 1893 1904 2-s2.0-0024814687 (Pubitemid 20026075)
9. Clark W. H. Jr., From L., Bernardino E. A., Mihm M. C., The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Research 1969 29 3 705 727 2-s2.0-0014481136
10. Breslow A., Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Annals of Surgery 1975 182 5 572 575 2-s2.0-0016766176
11. Halpern A. C., Marghoob A. A., Thin melanoma: still "excellent prognosis" disease? Journal of Clinical Oncology 2004 22 18 3651 3653 2-s2.0-4644252338 10.1200/JCO.2004.06.921 (Pubitemid 41095201)
12. Elder D. E., Thin melanoma. Archives of Pathology and Laboratory Medicine 2011 135 3 342 346
13. Thompson J. F., Soong S., Balch C. M., Gershenwald J. E., Ding S., Coit D. G., Flaherty K. T., Gimotty P. A., Johnson T., Johnson M. M., Leong S. P., Ross M. I., Byrd D. R., Cascinelli N., Cochran A. J., Eggermont A. M., McMasters K. M., Mihm M. C. Jr., Morton D. L., Sondak V. K., Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American joint committee on cancer melanoma staging database. Journal of Clinical Oncology 2011 29 16 2199 2205 2-s2.0-79957929511 10.1200/JCO.2010.31.5812
14. Balch C. M., Gershenwald J. E., Soong S., Thompson J. F., Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. Journal of Surgical Oncology 2011 104 4 379 385 2-s2.0-80051967437 10.1002/jso.21876
15. Azzola M. F., Shaw H. M., Thompson J. F., Soong S., Scolyer R. A., Watson G. F., Colman M. H., Zhang Y., Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer 2003 97 6 1488 1498 2-s2.0-0037443589 10.1002/cncr.11196 (Pubitemid 36297779)
16. Francken A. B., Shaw H. M., Thompson J. F., Soong S., Accortt N. A., Azzola M. F., Scolyer R. A., Milton G. W., McCarthy W. H., Colman M. H., McGovern V. J., The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Annals of Surgical Oncology 2004 11 4 426 433 2-s2.0-3042732836 10.1245/ASO.2004.07.014 (Pubitemid 40486754)
17. Gimotty P. A., Guerry D., Prognostication in thin cutaneous melanomas. Archives of Pathology and Laboratory Medicine 2010 134 12 1758 1763 2-s2.0-78650445664
18. Gershenwald J. E., Thompson W., Mansfield P. F., Lee J. E., Colome M. I., Tseng C., Lee J., Balch C. M., Reintgen D. S., Ross M. I., Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. Journal of Clinical Oncology 1999 17 3 976 983 2-s2.0-0032977814 (Pubitemid 29109331)
19. Boland G. M., Gershenwald J. E., Sentinel lymph node biopsy in melanoma. Cancer Journal 2012 18 2 185 191 2-s2.0-84859460328 10.1097/PPO.0b013e31825046c7
20. Gershenwald J. E., Ross M. I., Sentinel-lymph-node biopsy for cutaneous melanoma. The New England Journal of Medicine 2011 364 18 1738 1745 2-s2.0-79955726892 10.1056/NEJMct1002967
21. Morton D. L., Wen D. R., Wong J. H., Economou J. S., Cagle L. A., Storm F. K., Foshag L. J., Cochran A. J., Technical details of intraoperative lymphatic mapping for early stage melanoma. Archives of Surgery 1992 127 4 392 399 2-s2.0-0026590057
22. Andtbacka R. H. I., Gershenwald J. E., Role of sentinel lymph node biopsy in patients with thin melanoma. Journal of the National Comprehensive Cancer Network 2009 7 3 308 317 2-s2.0-63449113394
23. Schmoeckel C., Braun-Falco O., Prognostic index in malignant melanoma. Archives of Dermatology 1978 114 6 871 873 2-s2.0-0018232991 10.1001/archderm.114.6.871 (Pubitemid 9202393)
24. McGovern V. J., Cochran A. J., van der Esch E. P., The classification of malignant melanoma, its histological reporting and registration: a revision of the 1972 Sydney classification. Pathology 1986 18 1 12 21 2-s2.0-0022655163 (Pubitemid 16118166)
25. Prieto V. G., Sentinel lymph nodes in cutaneous melanoma: handling, examination, and clinical repercussion. Archives of Pathology and Laboratory Medicine 2010 134 12 1764 1769 2-s2.0-78650495423
26. Prieto V. G., Clark S. H., Processing of sentinel lymph nodes for detection of metastatic melanoma. Annals of Diagnostic Pathology 2002 6 4 257 264 2-s2.0-0036667571 10.1053/adpa.2002.35400
27. Prieto V. G., Sentinel Lymph Node Biopsy in Melanoma Pathology 2011 Medscape edited by J. A. Reed
28. Sekula-Gibbs S. A., Shearer M. A., Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one. Dermatologic Surgery 2011 37 8 1080 1088 2-s2.0-79961021743 10.1111/j.1524-4725.2011.02015.x
29. Piris A., Mihm M. C. Jr., Duncan L. M., AJCC melanoma staging update: impact on dermatopathology practice and patient management. Journal of Cutaneous Pathology 2011 38 5 394 400 2-s2.0-79953295774 10.1111/j.1600-0560.2011.01699.x
30. Dickson P. V., Gershenwald J. E., Staging and prognosis of cutaneous melanoma. Surgical Oncology Clinics of North America 2011 20 1 1 17 2-s2.0-78649460689 10.1016/j.soc.2010.09.007
31. Gershenwald J. E., Coit D. G., Sondak V. K., Thompson J. F., The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanomas. Annals of Surgical Oncology 2012 19 11 3301 3303 10.1245/s10434-012-2562-5
32. Ross M. I., Gershenwald J. E., Evidence-based treatment of early-stage melanoma. Journal of Surgical Oncology 2011 104 4 341 353 2-s2.0-80051987668 10.1002/jso.21962
33. Yonick D. V., Ballo R. M., Kahn E., Dahiya M., Yao K., Godellas C., Shoup M., Aranha G. V., Predictors of positive sentinel lymph node in thin melanoma. The American Journal of Surgery 2011 201 3 324 328 2-s2.0-79952137514 10.1016/j.amjsurg.2010.09.011
34. Murali R., Haydu L. E., Quinn M. J., Saw R. P. M., Shannon K., Spillane A. J., Stretch J. R., Thompson J. F., Scolyer R. A., Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma. Annals of Surgery 2012 255 1 128 133 2-s2.0-84155162859 10.1097/SLA.0b013e3182306c72
35. Testori A., de Salvo G. L., Montesco M. C., Trifirò G., Mocellin S., Landi G., MacRipò G., Carcoforo P., Ricotti G., Giudice G., Picciotto F., Donner D., Di Filippo F., Soteldo J., Casara D., Schiavon M., Vecchiato A., Pasquali S., Baldini F., Mazzarol G., Rossi C. R., Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Annals of Surgical Oncology 2009 16 7 2018 2027 2-s2.0-67649198517 10.1245/s10434-008-0273-8
36. Morris K. T., Busam K. J., Bero S., Patel A., Brady M. S., Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy. Annals of Surgical Oncology 2008 15 1 316 322 2-s2.0-38049141619 10.1245/s10434-007-9675-2
37. McClain S. E., Shada A. L., Barry M., Patterson J. W., Slingluff C. L. Jr., Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma. Melanoma Research 2012 22 4 302 309 10.1097/CMR.0b013e328353e673
38. Burton A. L., Gilbert J., Farmer R. W., Stromberg A. J., Hagendoorn L., Ross M. I., Martin R. C. G. II, McMasters K. M., Scoggins C. R., Callender G. G., Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. The American Surgeon 2011 77 8 1009 1013 2-s2.0-80052063857
39. Oláh J., Gyulai R., Korom I., Varga E., Dobozy A., Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas. The British Journal of Dermatology 2003 149 3 662 663 2-s2.0-0142088899 10.1046/j.1365-2133.2003.05502.x (Pubitemid 37281612)
40. Guitart J., Lowe L., Piepkorn M., Prieto V. G., Rabkin M. S., Ronan S. G., Shea C. R., Tron V. A., White W., Barnhill R. L., Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. Archives of Dermatology 2002 138 5 603 608 2-s2.0-0036578896
41. Wright B. E., Scheri R. P., Ye X., Faries M. D., Turner R. R., Essner R., Morton D. L., Importance of sentinel lymph node biopsy in patients with thin melanoma. Archives of Surgery 2008 143 9 892 899 2-s2.0-52249114520 10.1001/archsurg.143.9.892
42. Nading M. A., Balch C. M., Sober A. J., Implications of the 2009 American joint committee on cancer melanoma staging and classification on dermatologists and their patients. Seminars in Cutaneous Medicine and Surgery 2010 29 3 142 147 2-s2.0-78049524421 10.1016/j.sder.2010.06.004
43. Murali R., Haydu L. E., Long G. V., Quinn M. J., Saw R. P. M., Shannon K., Spillane A. J., Stretch J. R., Kefford R. F., Thompson J. F., Scolyer R. A., Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma. Annals of Surgical Oncology 2012 19 6 1782 1789 2-s2.0-84856796271 10.1245/s10434-012-2265-y
44. Koshenkov V. P., Shulkin D., Bustami R., Chevinsky A. H., Whitman E. D., Role of sentinel lymphadenectomy in thin cutaneous melanomas with positive deep margins on initial biopsy. Journal of Surgical Oncology 2012 106 4 363 368 2-s2.0-84858134440 10.1002/jso.23093
45. McKinnon J. G., Yu X. Q., McCarthy W. H., Thompson J. F., Prognosis for patients with thin cutaneous melanoma: long-term survival data from the New South Wales central cancer registry and the Sydney melanoma unit. Cancer 2003 98 6 1223 1231 2-s2.0-0041917102 10.1002/cncr.11624 (Pubitemid 37099907)
46. Ranieri J. M., Wagner J. D., Wenck S., Johnson C. S., Coleman J. J. III, The prognostic importance of sentinel lymph node biopsy in thin melanoma. Annals of Surgical Oncology 2006 13 7 927 932 2-s2.0-33745238097 10.1245/ASO.2006.04. 023
47. Faries M. B., Wanek L. A., Elashoff D., Wright B. E., Morton D. L., Predictors of occult nodal metastasis in patients with thin melanoma. Archives of Surgery 2010 145 2 137 142 2-s2.0-77149158501 10.1001/archsurg.2009.271
48. Puleo C. A., Messina J. L., Riker A. I., Glass L. F., Nelson C., Cruse C. W., Johnson T. M., Sondak V. K., Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control 2005 12 4 230 235 2-s2.0-27644561781 (Pubitemid 41552314)
49. Han D., Yu D., Zhao X., Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm. Annals of Surgical Oncology 2012 19 11 3335 3342 10.1245/s10434-012-2469-1
50. Caudle A. S., Ross M. I., Prieto V. G., Warneki C. L., Lee J. E., Johnson M. M., Gardner J. M., Royal R. E., Cormier J. N., Lucci A., Gershenwald J. E., Mitotic rate predicts sentinel lymph node involvement in melanoma: impact of the 7th edition AJCC melanoma staging system. Annals of Surgical Oncology 2010 17 8
51. Murali R., Scolyer R. A., Thompson J. F., Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death? Annals of Surgical Oncology 2012 19 11 3310 3312 10.1245/s10434-012-2470-8
52. Ivan D., Prieto V. G., An update on reporting histopathologic prognostic factors in melanoma. Archives of Pathology and Laboratory Medicine 2011 135 7 825 829 2-s2.0-79960832267